Search

everythinglearnresearchcommunity

for

Search:↓

ZSYY001 is safe, well-tolerated, and shows promise for treating advanced solid tumors.

Standardized protocols are crucial for safe and infection-free platelet-rich plasma therapy.

Research on HIV-1 capsid inhibitors has progressed significantly, with the U.S. leading in contributions.

Some people developed alopecia areata after COVID-19 vaccination, but it's not caused by the vaccine and most improved with treatment.

Peptide nanoparticles can effectively deliver CRISPR-Cas9 to target KRAS mutations in cancer.

Eculizumab helps reduce blood transfusions and stabilize hemoglobin but increases infection risk and is expensive.

Tofacitinib may be safe for COVID-19 patients with alopecia without worsening symptoms, based on two cases.

Newly designed proteins can effectively degrade specific proteins in cells, offering a promising alternative for targeted protein degradation.

CP-690,550 significantly reduced itching in patients with moderate-to-severe plaque psoriasis.

TAK-279 effectively reduces psoriasis symptoms and is safe.

Some small molecule antivirals show promise against COVID-19, but more research is needed to understand and improve them.

Combining PEMF with PBST is more effective for hair regrowth than PBST alone.

Tofacitinib is a promising treatment for children with rheumatic diseases.

The document concludes that more research is needed on the hepatitis B vaccine's side effects and the effectiveness of certain treatments for specific diseases.

Ixekizumab helps improve life quality, physical ability, and work performance in patients with psoriatic arthritis who haven't used biologic drugs before.

The document's conclusion cannot be provided because the document is not accessible or understandable.

Microneedles offer a promising, painless, and efficient way to deliver vaccines and therapies directly to the skin.

Some vaccines might rarely cause hair loss, more research is needed.

Taking sildenafil and finasteride together is safe and improves urinary and sexual symptoms in BPH patients.

The drug showed promise in treating renal cell carcinoma with manageable side effects.

Tenofovir alafenamide fumarate is effective and safer for hepatitis B, with fewer side effects than tenofovir disoproxil fumarate.

BI 2536 had limited effectiveness against several advanced cancers and caused significant side effects.

Tofacitinib helped regrow hair in a woman with alopecia areata.

Enfortumab vedotin can cause skin issues, especially in older males, needing early monitoring.

Ritlecitinib is the first FDA-approved pill for treating significant hair loss in alopecia areata patients aged 12 and up.

The drug Olumiant is now approved to treat severe hair loss from alopecia and can also be used for some hospitalized COVID-19 patients.

Dalpiciclib is the safest and most satisfying CDK4/6 inhibitor for advanced breast cancer patients in China.

Some people in Saudi Arabia experienced hair loss after the COVID-19 vaccine, more often in women and those without prior hair loss.

Cepharanthine shows promise as a COVID-19 treatment.